Skip to content

Clinical trials

Completed Lung Neoplasms trials in India

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Status: Completed Country / region: India Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20073
20085
20104
20131
20141
20151
20171
20182
20191
20202
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Post Graduate Institute of Medical Education and Research, Chandigarh4
Novartis Pharmaceuticals3
AstraZeneca2
Genzyme, a Sanofi Company2
Peregrine Pharmaceuticals2
Tata Memorial Hospital2
BioMarck Pharmaceuticals, Ltd.1
Bristol-Myers Squibb1
CSL Behring1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms25
Carcinoma, Non-Small-Cell Lung15
Adenocarcinoma of Lung2
Carcinoma2
Bronchial Neoplasms1
Cachexia1
Cough1
Fatigue1
Lung Diseases1
Lung Diseases, Interstitial1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.